Sort
4,870 grants matching “glp 1”
Development of Anorexigenic and Glucoregulatory Chimeric Peptides
$644,494Christian Ludwig Roth · Seattle Children'S Hospital · R01 · FY2024 · DK
Advancing the small molecule drug candidate with dual specificity as a therapy for dry AMD
$644,338Konstantin Petrukhin · Columbia University Health Sciences · R61 · FY2025 · EY
Neural Bases of Cephalic Phase Endocrine Responses
$643,900Alan C Spector · Florida State University · R01 · FY2019 · DK
Validation of Immunometabolic NLRX1 Therapeutics for IBD
$643,417Andrew Leber · Biotherapeutics, Inc. · R44 · FY2021 · DK
Novel Inhibitors of Lysine Methyltransferases G9a and GLP for the Treatment of Alzheimer's Disease
$643,355Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Processes mediated by polypeptides
$643,125Samuel H. Gellman · University Of Wisconsin-Madison · R35 · FY2025 · GM
Microtubule Regulation of Pancreatic Beta Cell Function and Diabetes
$643,069Irina Kaverina · Vanderbilt University · R01 · FY2023 · DK
Multi-receptor Targeting of Glioblastoma
$642,795Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2021 · CA
Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
$642,653Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2024 · DK
Novel Vaccine Technology for Chikungunya
$641,963Scott C Weaver · University Of Texas Med Br Galveston · R01 · FY2014 · AI
Bioabsorbable Magnesium (Mg) Implants for Craniomaxillofacial Surgical Systems
$641,612Stephen Lebeau · Nanomag, Llc · R44 · FY2018 · DE
Optimization of Substituted Phenoxyalkyl Pyridinium Oximes as Therapies for Organophosphate Poisoning
$641,224Janice E. Chambers · Mississippi State University · U01 · FY2025 · NS
Preclin. Test of Biodefense Drug for SEB Toxin Exposure
$640,895J. Joseph Kim · Viral Genomix, Inc. · R43 · FY2006 · AI
Peroxynitrite decomposition catalyst for bowel disease
$640,351Inotek Pharmaceuticals Corporation · R44 · FY2003 · DK
*Enhancement of tumor targeting and chemotherapeutic ac*
$640,099Endocyte, Inc. · R44 · FY2005 · CA
Nano-scale proteomic analysis: development, implementation, and applications
$640,087Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT)
$639,978Melena D. Bellin · University Of Minnesota · R01 · FY2025 · DK
Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation
$639,550Bart C De Jonghe · University Of Pennsylvania · R01 · FY2023 · DK
Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation
$639,550Bart C De Jonghe · University Of Pennsylvania · R01 · FY2025 · DK
Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT)
$639,164Melena D. Bellin · University Of Minnesota · R01 · FY2022 · DK
High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy
$639,117Babak Nazer · University Of Washington · R01 · FY2024 · HL
EGFRwt and EGFRvlll Dual-Specific Immunotoxin for Glioblastoma Multiforme
$638,550Darell D Bigner · Duke University · P01 · FY2014 · CA
Engineered Glucose Metabolism in Insulin Secreting Cells
$637,850Christopher B Newgard · Duke University · R01 · FY2022 · DK
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
$637,111Aaron Richard McCabe · Minnetronix, Inc. · R42 · FY2020 · CA
Spring System for Permanent Relief of Urinary Obstruction related to Benign Prostatic Hyperplasia
$636,601Nicholas Damiano · Zenflow, Inc. · R44 · FY2017 · DK